Abraham Ceesay
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Abraham Ceesay
Abraham Ceesay is recorded as Board Member and CEO at Charles River Laboratories International, Inc. (CRL). Charles River Laboratories International, Inc. reported in an 8-K filed May 11, 2026 that Abraham Ceesay was appointed director, effective May 5, 2026. Charles River Laboratories International, Inc. reported in an 8-K filed May 23, 2025 that Abraham Ceesay was appointed to the Board, effective May 20, 2025. Charles River Laboratories International, Inc. reported in an 8-K filed May 7, 2025 that Abraham Ceesay was appointed New Company Director.
“The following twelve (12) directors were elected to serve until our 2027 Annual Meeting of Shareholders and received the number of votes listed opposite each of their names below:”
“On May 20, 2025, the Board appointed Steven Barg, Mark Enyedy, Abraham Ceesay, and Paul Graves to the Board, each with a term expiring at the 2026 Annual Meeting of Shareholders.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Charles River Laboratories International, Inc.
Other people whose current roles at this company are on record from its filings.
- Craig B. Thompson CEO, Board Member
- James C. Foster CEO, Board Member
- James Foster CEO, Board Member
- Mark Enyedy CEO, Board Member
- Martin W. Mackay CEO, Board Member
- Paul Graves CEO, Board Member
- Reshema Kemps-Polanco CEO, Board Member
- George M. Milne Chairman
- Martin Mackay Chairman
- Michael G. Knell CFO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.